LRMR
Larimar TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
LRMR vs peer average
34/100
LRMR vs. peer average (D vs. C)
Grade spread
A 4 · B 1 · D 1 · F 4
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
DSGN is the first available peer comparator.
Same-indication development comparator with a different mechanism and clinical stage; useful for competitive-program context, not a like-for-like price target. [Design investor release](https://investors.designtx.com/news-releases/news-release-details/design-therapeutics-provides-restore-fa-clinical-development)
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
LRMR
Larimar Therapeutics
DSGN
Design Therapeutics
Grade
D
A
Momentum
13
17
Value
41
41
Sentiment
51
92
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs DSGN
LRMR / DSGN
Grade Position
Below peers
LRMR vs. peer average (D vs. C)
34/100
Momentum
13
DSGNValue
41
LRMRSentiment
51
DSGNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs LRMR
DSGN is the first peer returned for this comparison set.